Trials / Unknown
UnknownNCT01597999
Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer
Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.
Detailed description
Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | MRI | magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-07-01
- Completion
- 2013-12-01
- First posted
- 2012-05-15
- Last updated
- 2013-01-23
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01597999. Inclusion in this directory is not an endorsement.